MCID: CHS005
MIFTS: 20

Chest Wall Lymphoma

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Chest Wall Lymphoma

MalaCards integrated aliases for Chest Wall Lymphoma:

Name: Chest Wall Lymphoma 12 15 74
Malignant Neoplasm of Chest Wall 12
Malignant Tumor of Chest Wall 12
Lymphoma of the Chest Wall 12
Lymphoma of Chest Wall 12
Chest Wall Cancer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6758
NCIt 51 C4580 C6712
SNOMED-CT 69 93754006

Summaries for Chest Wall Lymphoma

Disease Ontology : 12 A thoracic cancer that is located in the chest wall.

MalaCards based summary : Chest Wall Lymphoma, also known as malignant neoplasm of chest wall, is related to chest wall bone cancer and lymphoma. An important gene associated with Chest Wall Lymphoma is SFTPD (Surfactant Protein D). The drugs Talimogene laherparepvec and Antineoplastic Agents, Immunological have been mentioned in the context of this disorder. Affiliated tissues include the chest wall and breast, and related phenotype is Negative genetic interaction between PTEN-/- and PTEN+/+.

Related Diseases for Chest Wall Lymphoma

Diseases related to Chest Wall Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 chest wall bone cancer 11.2
2 lymphoma 10.0
3 burkitt lymphoma 9.9
4 anaplastic large cell lymphoma 9.9
5 b-cell lymphomas 9.9
6 diffuse large b-cell lymphoma 9.9
7 congenital eyelid retraction 9.9

Graphical network of the top 20 diseases related to Chest Wall Lymphoma:



Diseases related to Chest Wall Lymphoma

Symptoms & Phenotypes for Chest Wall Lymphoma

GenomeRNAi Phenotypes related to Chest Wall Lymphoma according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Negative genetic interaction between PTEN-/- and PTEN+/+ GR00255-A-3 8.62 SFTPD TWIST1

Drugs & Therapeutics for Chest Wall Lymphoma

Drugs for Chest Wall Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Talimogene laherparepvec Approved, Experimental, Investigational Phase 2 1187560-31-1
2 Antineoplastic Agents, Immunological Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery Recruiting NCT02658812 Phase 2

Search NIH Clinical Center for Chest Wall Lymphoma

Genetic Tests for Chest Wall Lymphoma

Anatomical Context for Chest Wall Lymphoma

The Foundational Model of Anatomy Ontology organs/tissues related to Chest Wall Lymphoma:

20
The Chest Wall

MalaCards organs/tissues related to Chest Wall Lymphoma:

42
Breast

Publications for Chest Wall Lymphoma

Articles related to Chest Wall Lymphoma:

# Title Authors Year
1
Primary chest wall lymphoma: A rare entity. ( 26458675 )
2015
2
Primary chest wall lymphoma with no history of tuberculous pyothorax: diagnosis and treatment. ( 19114192 )
2008

Variations for Chest Wall Lymphoma

Expression for Chest Wall Lymphoma

Search GEO for disease gene expression data for Chest Wall Lymphoma.

Pathways for Chest Wall Lymphoma

GO Terms for Chest Wall Lymphoma

Sources for Chest Wall Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....